STERICALLY STABILIZED LIPOSOMES - IMPROVEMENTS IN PHARMACOKINETICS AND ANTITUMOR THERAPEUTIC EFFICACY

被引:1417
作者
PAPAHADJOPOULOS, D
ALLEN, TM
GABIZON, A
MAYHEW, E
MATTHAY, K
HUANG, SK
LEE, KD
WOODLE, MC
LASIC, DD
REDEMANN, C
MARTIN, FJ
机构
[1] UNIV CALIF SAN FRANCISCO, CANC RES INST, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA
[2] UNIV ALBERTA, DEPT PHARMACOL, EDMONTON T6G 2E1, ALBERTA, CANADA
[3] HADASSAH MED CTR, DEPT ONCOL, IL-91120 JERUSALEM, ISRAEL
[4] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT EXPTL PATHOL, BUFFALO, NY 14263 USA
[5] LIPOSOME TECHNOL INC, MENLO PK, CA 94025 USA
关键词
D O I
10.1073/pnas.88.24.11460
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The results obtained in this study establish that liposome formulations incorporating a synthetic polyethylene glycol-derivatized phospholipid have a pronounced effect on liposome tissue distribution and can produce a large increase in the pharmacological efficacy of encapsulated antitumor drugs. This effect is substantially greater than that observed previously with conventional liposomes and is associated with a more than 5-fold prolongation of liposome circulation time in blood, a marked decrease in uptake by tissues such as liver and spleen, and a corresponding increased accumulation in implanted tumors. These and other properties described here have expanded considerably the prospects of liposomes as an effective carrier system for a variety of pharmacologically active macromolecules.
引用
收藏
页码:11460 / 11464
页数:5
相关论文
共 51 条
[1]   LIPOSOME DISPOSITION INVIVO .3. DOSE AND VESICLE-SIZE EFFECTS [J].
ABRA, RM ;
HUNT, CA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 666 (03) :493-503
[2]  
ALLEN T M, 1989, P405
[3]  
Allen T M, 1989, Proc West Pharmacol Soc, V32, P111
[4]   PHOSPHATIDYLSERINE AS A DETERMINANT OF RETICULOENDOTHELIAL RECOGNITION OF LIPOSOME MODELS OF THE ERYTHROCYTE SURFACE [J].
ALLEN, TM ;
WILLIAMSON, P ;
SCHLEGEL, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :8067-8071
[5]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[6]   UPTAKE OF LIPOSOMES BY CULTURED MOUSE BONE-MARROW MACROPHAGES - INFLUENCE OF LIPOSOME COMPOSITION AND SIZE [J].
ALLEN, TM ;
AUSTIN, GA ;
CHONN, A ;
LIN, L ;
LEE, KC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1061 (01) :56-64
[7]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[8]   LIPOSOMES CONTAINING SYNTHETIC LIPID DERIVATIVES OF POLY(ETHYLENE GLYCOL) SHOW PROLONGED CIRCULATION HALF-LIVES INVIVO [J].
ALLEN, TM ;
HANSEN, C ;
MARTIN, F ;
REDEMANN, C ;
YAUYOUNG, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (01) :29-36
[9]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[10]  
ALLEN TM, 1983, J PHARMACOL EXP THER, V226, P539